Name, definition, and product boundary
Wearable circadian light stimulation eye masks place a controllable light source in front of the eyes and deliver scheduled ocular light while the user is awake, resting with closed eyes, or asleep, with the aim of changing circadian phase, morning or evening light exposure, or alertness. Within WSIC, they are classified under 1.2.2 Neuromodulation assistive devices. Their defining elements are dose at the eye plus timing; they are not ordinary blackout masks decorated with colored lights, nor a collective term for every illuminated cosmetic mask.
Products may use LEDs inside a mask, transmitting light guides, or near-eye optics and may emit continuously, ramp gradually, or pulse. Some deliver light through closed eyelids before waking, whereas others require awake, eyes-open use. A mask that only blocks light is a sleep mask, and a bedside sunrise lamp is an environmental light device. Red or near-infrared skin treatments, transcranial photobiomodulation, and retinal disease treatments have different target tissues, wavelengths, doses, and regulatory boundaries and do not share evidence merely because all are called light therapy.
“Circadian regulation” means that light may act as a time cue; it does not mean that exposure at any clock time promotes sleep. The same stimulus can shift the clock in opposite directions at different internal phases, and mistimed exposure can move sleep onset or wake time farther from the goal. Claims concerning delayed or advanced sleep-wake phase disorder, shift work, or jet lag require a defined population, phase assessment, exposure protocol, and follow-up. A general-wellness label cannot replace evidence for diagnosis or treatment of a disorder.
Circadian mechanism, phase, and intended goal
Light reaching the retina can engage rods, cones, and melanopsin-containing intrinsically photosensitive retinal ganglion cells in nonvisual responses such as melatonin suppression, alerting effects, and circadian phase resetting. Response depends jointly on spectrum, retinal irradiance, duration, pulse pattern, field of view, pupil behavior, prior light history, age, and internal phase. Calling one wavelength a “body-clock switch,” or predicting all responses from a color name, oversimplifies this multi-receptor system.
The phase-response curve to light shows that exposure at different parts of the biological night can favor delays or advances, with periods of smaller response between them. A protocol should not specify only “before bed,” “during the night,” or “before waking.” The device clock must be related to actual sleep timing, time zone, intended direction, and the best available marker of internal phase. Repeated travel, weekend catch-up sleep, rotating shifts, and daylight-saving changes can invalidate an old schedule.
Circadian phase movement, sleep that night, and next-day alertness are distinct outcomes. A shift in the desired direction may not immediately improve sleep efficiency, and a short-term alerting effect may interfere with sleep if delivered at the wrong time. The target should state whether sleep and wake are to move earlier, move later, whether early waking is to be reduced, alertness is to be supported on a particular shift, or an established rhythm is to be maintained. Optimizing only an app’s “circadian score” can conceal changes that conflict with real-life obligations.
Optical dose and measurement language
A complete dose includes spectrum at the eye, irradiance or an appropriate photometric quantity, session and cumulative duration, pulse width, frequency, duty cycle, waveform, distribution between eyes, field of view, and circadian timing. Ordinary illuminance is weighted for photopic vision and does not fully describe stimulation of all retinal photoreceptor classes. CIE S 026 defines five alpha-opic quantities and metrics such as melanopic EDI for traceable characterization, but these metrics do not by themselves prescribe efficacy or safety thresholds.
Closed eyelids substantially attenuate light, and transmittance varies with wavelength, lid thickness, and individual anatomy; short wavelengths are generally attenuated more strongly. Lux measured at the housing, in free air, or with eyes open therefore does not directly represent the stimulus reaching the retina through a lid. If a product claims to compensate automatically for lid transmission or pupil behavior, it should disclose calibration, maximum output, individual estimation error, and limits applied when compensation fails. Uncertainty must not be overcome by unlimited brightening.
Pulsed light requires both peak and time-averaged quantities. The same average power can be produced by different peaks, pulse widths, and duty cycles, with different visual sensations and biological responses; an app percentage is not a unit transferable between devices. Photobiological safety must be assessed at the intended near-eye distance, maximum accessible output, pulse sequence, and foreseeable misuse. A measurement chosen for circadian efficacy does not replace evaluation of retinal blue-light hazard, thermal hazard, or ultraviolet and infrared leakage.
Construction, fit, and control system
A system commonly includes left and right light sources, diffusers or guides, a light-blocking cavity, controller, clock, sensors, battery, soft mask body, and straps. Diffusers should prevent local hot spots, output and angle should be controlled for each eye, and hardware must not press directly on the globe. Nose gaps, eyelash contact, facial curvature, strap tension, and side-sleep deformation alter leakage, distance, and uniformity, so output measured with a mask lying flat does not represent output while worn.
Timing may be based on a fixed clock, alarm, sleep diary, activity record, or an algorithm’s estimate of sleep and circadian phase. An estimate should expose uncertainty and request confirmation after missing data, travel, abrupt schedule change, or sensor failure. Treating wrist movement or one night’s sleep score as a precise internal phase can schedule the stimulus in the wrong direction. The mask’s clock, battery state, and time-zone update should be checked before every planned run.
Reliable control includes an output ceiling, ramp-up or ramp-down, a maximum run time, per-session and daily lockouts, left-right fault detection, and immediate stop. On low battery, frozen firmware, app disconnection, or schedule synchronization failure, the mask should stay off or enter a documented bounded state rather than illuminate unexpectedly all night. The user should be able to stop light on the mask itself; an alarm, indicator, or wireless connection must not be the sole route to shutoff.
Protocol planning and practical use
First use should occur while awake so the user can inspect light, occlusion, timing, the stop control, comfort, and flicker intolerance before trying a conservative protocol. When clinical phase shifting is the goal, at least one to two weeks of sleep diary and, when appropriate, activity recording can establish the habitual schedule. A qualified professional can then consider symptoms, medication, ocular status, and desired direction. Another person’s clock time, an online jet-lag table, or a device default should not be copied uncritically.
Wake time, indoor and outdoor light, darkness, naps, and shift patterns should be recorded because a mask supplies only one part of the 24-hour light history. A morning mask session may be undermined by dim conditions afterward, and an evening plan may be altered by phone, room, or outdoor light. If melatonin or a medicine affecting sleep, alertness, or photosensitivity is also used, the prescriber should know. The direction and dose of multiple time cues should not be layered casually.
Records should include actual start time, run duration, output setting, leakage or displacement, awakenings, symptoms, sleep and wake time, and next-day function. Phase markers such as dim-light melatonin onset can support research or specialist assessment, but an app-generated home phase remains an estimate. Protocol changes should use trends over days to weeks and limit the size of each adjustment; one unsuccessful night is not a reason to keep advancing, delaying, or increasing output.
Evidence hierarchy and outcome evaluation
Controlled studies show that selected blue-light pulses delivered through closed eyelids can suppress melatonin or shift circadian phase in some adults. In one home study of 28 healthy older adults and people with early waking, an individually timed blue condition delayed dim-light melatonin onset by roughly half an hour on average and delayed sleep start, but did not improve sleep efficiency. This supports physiological feasibility of that specific protocol, not effectiveness of every wavelength, mask, schedule, or population.
A randomized crossover study from the same research program found improvement in some subjective reports under both active blue and red control conditions, with no significant difference between them and no intervention effect on actigraphic sleep start, total sleep time, or efficiency. An earlier delayed-sleep-phase mask trial reported earlier phase and sleep timing in a subgroup whose baseline phase was especially late. Subgroup selection, accompanying schedule changes, small samples, and perceptible controls complicate interpretation; a phase shift must not be rewritten as universal improvement in sleep quality.
A finished product should use a comparator that matches its claim, record actual dose at the eye and wearing adherence, and prespecify circadian markers, sleep diary, actigraphy, next-day alertness, and adverse effects as distinct endpoints. Different colors may not create credible blinding, and an app estimate cannot validate the algorithm that generated it. Professional guidelines support strategically timed light only for selected circadian sleep-wake disorders and conditions, often conditionally. That evidence cannot be transferred automatically to through-lid, pulsed, or consumer near-eye devices.
Safety, maintenance, and stop conditions
Near-eye sources should have traceable spectral and maximum-output data and appropriate photobiological, electrical, battery, material, and temperature-rise assessments. Conventional light-therapy studies in healthy people not taking photosensitizing drugs have not shown a clear pattern of ocular injury, but eye discomfort and visual symptoms occur. Evidence is limited for people with existing eye disease, recent ocular surgery, retinal risk, or photosensitizing medication; they should consult an eye-care professional or the prescriber before use.
Power off before cleaning and remove washable textiles only as instructed, keeping fluid out of the optical cavity. A scratched, clouded, or deformed diffuser can create nonuniform hot spots. Before use, inspect cables, housing, battery, source mounting, blackout liners, and the stop control. Stop for a cracked housing, exposed conductor, odor, abnormal heat, swollen battery, failure to turn off, or a sudden left-right brightness difference. Do not wear while charging, remove a diffuser, or modify output limits.
Stop promptly for eye pain, persistent afterimages, a substantial visual change, severe headache, nausea, vertigo, flicker-provoked symptoms, repeated awakenings, or sleep timing moving in the wrong direction. Sudden vision loss, a new visual-field defect, severe eye pain, persistent insomnia, or marked worsening of daytime function requires timely professional assessment. Related entries: closed-loop smart eye masks, sleep-rhythm regulation headwear, portable circadian light-regulation lamps, morning high-illuminance lamps, and blue-light-blocking sleep masks.